Drug packaging and delivery system company, Gerresheimer, noted the prefillable syringes business is booming as it reported double digit organic revenue growth in Q3 2021.
There is “sizable demand” from manufacturers of COVID-19 vaccines for vials out to 2023, suggesting that the market will remain significant for some time.
